Eurofarma Laboratorios

Eurofarma is the first Brazilian multinational pharmaceutical company, established in 1972, and has a strong presence in Latin America. It ranks as the second most prescribed laboratory by the Brazilian medical community and is among the top four generic drug manufacturers in Brazil. The company develops, produces, and commercializes a wide range of pharmaceutical products, including generic and prescription drugs, oncology treatments, and veterinary medicines. Eurofarma boasts the largest medical sales force in Brazil, with approximately 2,000 representatives, and has a significant focus on research and development to enhance its offerings. It operates its own facilities in 15 countries and has over 10 strategically located manufacturing plants. Licenses from third-party products contribute around 10% of its total sales, which reached approximately $1 billion in 2014, reflecting a 20% growth from the previous year. Eurofarma is recognized for its workplace quality and has an ambitious plan for international expansion.

Alexandre Palhares

Vice President of Finance and CFO

3 past transactions

Abcuro

Series B in 2023
Abcuro, Inc. is a biotechnology company focused on developing immunotherapies for the treatment of autoimmunity and cancer. Established in 2015 and headquartered in Newton, Massachusetts, Abcuro specializes in creating therapeutic antibodies that target novel pathways in these diseases. The company employs advanced bioinformatics to analyze transcription data from human diseases, enabling them to identify new therapeutic targets within the immune system. By leveraging clinical insights and systematic target validation, Abcuro aims to develop immune-modulatory biotherapeutics that provide innovative treatment options for patients suffering from autoimmune disorders and cancer.

JustForYou

Corporate Round in 2022
JustForYou is a manufacturer of personalized hair care products focused on improving the health and appearance of hair, nails, and skin. The company specializes in creating customized formulas for shampoos and conditioners, employing advanced technology and artificial intelligence to tailor solutions to individual needs. By analyzing hair characteristics, JustForYou formulates specialized products that address cleaning, hydration, treatment, and anti-frizz concerns. This innovative approach enables customers to receive targeted hair care solutions that promote better overall hair health.

Summit Therapeutics

Post in 2020
Summit Therapeutics Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, that specializes in the discovery, development, and commercialization of novel antibiotics aimed at treating serious infectious diseases. The company focuses on addressing Clostridium difficile infection (CDI) with its lead product candidate, ridinilazole, which is currently undergoing Phase III clinical trials. Additionally, Summit is developing the DDS-01 series to combat infections caused by Neisseria gonorrhoeae and the DDS-04 series targeting Enterobacteriaceae. With operations in the United States and Europe, Summit Therapeutics aims to establish new standards of care for patients while creating value for payors and healthcare providers. Founded in 2003, the company is committed to advancing innovative treatments for infectious diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.